Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded
- Contract number
- SPE2DR26FCQ0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,941
Award facts
- Contract value 100% obligated
- $27,941.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,941.01 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, on a firm fixed-price basis with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products globally to support military healthcare operations.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded delivery orders with the DLA covering a broad spectrum of medical supplies and pharmaceutical products. The OmniPod 5 pods being supplied under this order are insulin delivery devices designed for diabetes management, representing the type of specialized medical equipment and chronic disease management products the company routinely provides to Defense Health Agency customers and other federal healthcare systems through its established vendor relationships and comprehensive product distribution network.
Quick answers
Who was awarded contract SPE2DR26FCQ0Q?
SPE2DR26FCQ0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FCQ0Q worth?
The government has obligated $27,941 on SPE2DR26FCQ0Q.
Is contract SPE2DR26FCQ0Q an order under another contract?
Yes. SPE2DR26FCQ0Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCQ0Q competed?
The extent of competition for SPE2DR26FCQ0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award